Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
9h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
10h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
12h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
20h agoBuffalo Potash Files Annual Information Form and New Technical Report
21h agoIonik Announces 30-Day Extension of Senior Debt Facility
Nurexone Biologic Inc logo

Nurexone Biologic Inc

About

0.64CAD+0.00 +0.00%
Closed • Updated at 23:46 GMT+00:00
Market Cap$34.08M
Volume4.0K
Beta-0.15
RSI54.12
Health TechnologyPharmaceuticals: Major

Nurexone Biologic Inc — investor relations, events, news, and company updates on 6ix.

Latest News

May 19 2026
NurExone Receives Notice of Patent Grant in South Korea Covering ExoPTEN Technology
May 14 2026
NurExone Advances to Stage 2 of EU-Backed EIT Health Catapult Programme 2026
Apr 27 2026
Australian Patent Granted to NurExone Covering Stem Cell-Derived Exosome Production
Apr 16 2026
NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update
Apr 10 2026
NurExone to Participate in Water Tower Research Insights Conference on April 14, 2026

Community Chat

Ask AI

Try asking
6ix6ixAIEvents